Inventor · disambiguated record
David Reid
Also filed as: REID DAVID · REID DAVID R
8 granted patents·18 pending applications·74 citations·filing 1973–2025
84Inventor score
Files withMODERNATX INC14GEORGIA TECH RES INST3CAMBRIDGE ENTPR LTD2Helicon Chemical Company2REID DAVID2
Top patents by PatentIndex Score
26 records- 0177US8309590B2Triazol compounds for treating biofilm formationREID DAVID·Filed 2008·Granted Nov 13, 2012·4 cites·2 claims
- 0277US6244777B1One-use toothbrush assembly with external plug for releasing toothpaste from the interior, and method for using the sameGLOBAL CORP·Filed 2000·Granted Jun 12, 2001·29 cites·9 claims
- 0374US2025367278A1Variant strain-based coronavirus vaccinesMODERNATX INC·Filed 2025·Application pending·0 cites
- 0471US8592473B2Triazol compounds for treating biofilm formationREID DAVID·Filed 2012·Granted Nov 26, 2013·2 cites·16 claims
- 0566US2024139309A1Variant strain-based coronavirus vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 0664US2024264094A1Metasurface for Complex Permittivity Characterization of Dielectric Materials and the Use thereofGEORGIA TECH RES INST·Filed 2024·Application pending·0 cites
- 0764US2025221931A1Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemiaMODERNATX INC·Filed 2023·Application pending·0 cites
- 0864US2025313830A1Messenger ribonucleic acids with extended half-lifeMODERNATX INC·Filed 2023·Application pending·0 cites
- 0961US12469979B2Electromagnetic metastructures for radome or antennaeGEORGIA TECH RES INST·Filed 2021·Granted Nov 11, 2025·0 cites·20 claims
- 1061US2025251391A1Ribosomal engagement potency assayMODERNATX INC·Filed 2023·Application pending·0 cites
- 1160US2024376445A1Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndromeMODERNATX INC·Filed 2022·Application pending·0 cites
- 1259US2025017867A1Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular diseaseMODERNATX INC·Filed 2022·Application pending·0 cites
- 1358US2025162959A1Composite powder containing primary nanoparticles of aluminum or aluminum oxideHelicon Chemical Company·Filed 2023·Application pending·0 cites
- 1457US2024189449A1Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiencyMODERNATX INC·Filed 2022·Application pending·0 cites
- 1555US11017917B2Dielectric composite containing dispersed primary nanoparticles of aluminum or aluminum oxideHelicon Chemical Company·Filed 2019·Granted May 25, 2021·0 cites·12 claims
- 1655US2024100151A1Variant strain-based coronavirus vaccinesMODERNATX INC·Filed 2022·Application pending·0 cites
- 1754US2024229109A1Methods for identification and ratio determination of rna species in multivalent rna compositionsMODERNATX INC·Filed 2022·Application pending·0 cites
- 1853US2023406895A1Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNATX INC·Filed 2021·Application pending·0 cites
- 1953US2023242908A1Lnp compositions comprising mrna therapeutics with extended half-lifeMODERNATX INC·Filed 2021·Application pending·0 cites
- 2050US3979343ASurface coating compositions containing pigment coated with a polymeric organic polyolREED INTERNATIONAL LTD·Filed 1973·Granted Sep 7, 1976·6 cites·13 claims
- 2149US2021163928A1Messenger rna comprising functional rna elementsMODERNATX INC·Filed 2019·Application pending·0 cites
- 2248US2022387628A1Messenger rna comprising functional rna elements and uses thereofMODERNATX INC·Filed 2020·Application pending·0 cites
- 2346US10159685B2Vascular calcificationCAMBRIDGE ENTPR LTD·Filed 2017·Granted Dec 25, 2018·0 cites·13 claims
- 2446US2024310561A1Method and system with fragmented metastructures formed with a plurality of metasurface arraysGEORGIA TECH RES INST·Filed 2022·Application pending·0 cites
- 2542US5461814AScent dispenserFiled 1994·Granted Oct 31, 1995·33 cites·15 claims
- 2641US2021052632A1Selective parp1 inhibitors to treat cancerCAMBRIDGE ENTPR LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Reid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →